AQR Capital Management »

Actuate Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $74k 27k 2.74

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Bristol Myers Squibb (BMY)
Alphabet Cap Stk Cl A (GOOGL)
Edison International (EIX)
PG&E Corporation (PCG)
Alphabet Cap Stk Cl C (GOOG)
Comfort Systems USA (FIX)
Micron Technology (MU)
Booking Holdings (BKNG)
Ge Vernova (GEV)
Chubb (CB)

View all positions for AQR Capital Management

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Northern Trust
Texas Capital Bank Wealth Management Services
Vanguard Fiduciary Trust
State Street Corporation
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group
Deutsche Bank Aktiengesellschaft

View all funds holding Actuate Therapeutics